Cancer treatment is improving widely over time, but finding a proper defender to beat them seems like a distant dream. The quest for identification and discovery of drugs with an effective action is still a vital work. The role of a membrane protein called P-glycoprotein, which functions as garbage chute that efflux the waste, xenobiotics, and toxins out of the cancer cells acts as a major reason behind the therapeutic failure of most chemotherapeutic drugs. In this review, we mainly focused on a multiple strategies by employing 5-Fluorouracil, curcumin, and lipids in Nano formulation for the possible treatment of colorectal cancer and its metastasis. Eventually, multidrug resistance and angiogenesis can be altered and it would be helpful i...
Background: Colorectal cancer (CRC) is one of the main cancer related morbidity wordwidth. New thera...
The development of resistance toward current cancer therapy modalities is an ongoing challenge in gy...
Objective: Treatment of colorectal cancer (CRC) remains a clinical challenge, as more than 15 % of p...
Curcumin diffuses through cell membranes into the endoplasmic reticulum, mitochondria, and nucleus, ...
Curcumin is a polyphenol derived from Curcuma longa. Over the last few years, a number of studies ha...
Colorectal cancer remains the third largest cause of mortality from cancer related death, with appro...
Colorectal cancer (CRC) is the third most prevalent form of cancer, after lung cancer and breast can...
Colorectal cancer (CRC) is the third most prevalent form of cancer, after lung cancer and breast can...
There is growing concern in the rise of colorectal cancer (CRC) cases globally, and with this rise i...
Colorectal cancer (CRC) is the second leading cause of cancer death worldwide and mostly affects men...
Objective: Development of treatment resistance and adverse toxicity associated with classical chemot...
Curcumin, a polyphenol, has a wide range of biological properties such as anticancer, antibacterial,...
Development of treatment resistance and adverse toxicity associated with classical chemotherapeutic ...
Cancer is a major burden of disease globally. Each year, tens of millions of people are diagnosed wi...
Notwithstanding recent treatment advances in metastatic colorectal cancer (mCRC), chemotherapy with ...
Background: Colorectal cancer (CRC) is one of the main cancer related morbidity wordwidth. New thera...
The development of resistance toward current cancer therapy modalities is an ongoing challenge in gy...
Objective: Treatment of colorectal cancer (CRC) remains a clinical challenge, as more than 15 % of p...
Curcumin diffuses through cell membranes into the endoplasmic reticulum, mitochondria, and nucleus, ...
Curcumin is a polyphenol derived from Curcuma longa. Over the last few years, a number of studies ha...
Colorectal cancer remains the third largest cause of mortality from cancer related death, with appro...
Colorectal cancer (CRC) is the third most prevalent form of cancer, after lung cancer and breast can...
Colorectal cancer (CRC) is the third most prevalent form of cancer, after lung cancer and breast can...
There is growing concern in the rise of colorectal cancer (CRC) cases globally, and with this rise i...
Colorectal cancer (CRC) is the second leading cause of cancer death worldwide and mostly affects men...
Objective: Development of treatment resistance and adverse toxicity associated with classical chemot...
Curcumin, a polyphenol, has a wide range of biological properties such as anticancer, antibacterial,...
Development of treatment resistance and adverse toxicity associated with classical chemotherapeutic ...
Cancer is a major burden of disease globally. Each year, tens of millions of people are diagnosed wi...
Notwithstanding recent treatment advances in metastatic colorectal cancer (mCRC), chemotherapy with ...
Background: Colorectal cancer (CRC) is one of the main cancer related morbidity wordwidth. New thera...
The development of resistance toward current cancer therapy modalities is an ongoing challenge in gy...
Objective: Treatment of colorectal cancer (CRC) remains a clinical challenge, as more than 15 % of p...